Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-set pre-B cell surrogate light chain 3 (VPREB3) is a small glycoprotein expressed predominantly in early B cell precursors and germinal center B cells. It is a member of the immunoglobulin superfamily, structurally related to other surrogate light chain proteins such as VPREB1 and IGLL1, and typically functions as a component of the pre-B cell receptor complex. VPREB3 associates with immunoglobulin mu heavy chains in the endoplasmic reticulum, modulating their maturation and possibly their transport. While it is not deemed essential for B-cell development, its expression is a reliable marker of certain B-cell malignancies, serving as a valuable immunophenotypic biomarker for the diagnosis and classification of Burkitt lymphoma and some DLBCL subtypes, particularly those harboring c-MYC translocations. Outside hematopoietic tissues, VPREB3 is also found in Purkinje cells of the cerebellum and adrenal zona glomerulosa, but its function in these tissues remains unclear.
Null (No drugs target VPREB3 directly, so no mechanism of action is established).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-set pre-B cell surrogate light chain 3 (VPREB3).